Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Thymosin Beta-4 vs TB-500 — Peptide Comparison

Thymosin Beta-4 vs TB-500 — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

At a Glance

Quickcomparison

Dose Range

Thymosin Beta-4

2–5 mg

TB-500

Frequency

Twice weekly

Administration

Subcutaneous injection

Cycle Length

8-12 weeks

4-6 weeks

Onset Speed

Moderate (1-2 weeks)

Evidence Level

Moderate human trials (Phase 1-2)

Efficacy

Benefitratings

Wound Healing

Inflammation Reduction

Tissue Regeneration

Healing Speed

Tissue Repair

Anti-Scarring

Technical Data

Compoundspecifications

Molecular Formula

C212H350N56O78S

Molecular Weight

4963

Half-Life

Dose-dependent (increases with higher doses)

Bioavailability

100% (subcutaneous and intravenous)

CAS Number

77591-33-4

C38H68N10O14

889.01 g/mol

2-3 days (systemic)

High via subcutaneous injection (~100%)

885340-08-9

Protocols

Dosingtiers

standard

2-5 mg (community injectable practice for 'TB-500')

Once or twice weekly

4-6 week loading phase, then weekly maintenance

Documented community/research-practice injectable dosing for tissue repair; thymosin beta-4 has ~100% bioavailability by the subcutaneous route [1]. Not an FDA-approved use.

0.1% (1 mg/mL) RGN-259 solution, 1 drop

Several times daily (e.g. up to 5x/day)

4 weeks

0.1% RGN-259 ophthalmic solution used in phase III neurotrophic keratopathy and dry-eye trials, applied as eye drops several times daily for ~4 weeks [5].

advanced

450-1200 mg

IV push daily for the first 3 days, then weekly

Total of 7 doses over ~5 weeks

Doses studied in the RGN-352 acute myocardial infarction clinical program, given IV after PCI [6].

starting

2-2.5 mg

Loading phase, 4-6 weeks

Research peptide with no human trials of the fragment; loading doses used in practice [6].

Once weekly

Maintenance after loading

Maintenance dose used in practice following the loading phase [6].

Applications

Bestsuited for

Post-Surgery Recovery

Accelerates healing of surgical wounds and reduces post-operative inflammation and scarring

Chronic Wound Management

Helps pressure ulcers, venous stasis ulcers, and other slow-healing wounds progress faster

Supports repair of damaged tissues from injury, burns, or degenerative conditions

Athletes Recovering from Muscle Injuries

If you've pulled a hamstring, strained your back, or torn a muscle, TB-500 helps accelerate the healing process by promoting cell migration to the injury site and supporting new blood vessel growth. It's especially useful for injuries that just won't seem to fully heal.

Tendon and Ligament Problems

Tendons and ligaments are notoriously slow healers because they have poor blood supply. TB-500 promotes angiogenesis (new blood vessel formation) and helps repair these stubborn connective tissue injuries—think Achilles tendonitis, tennis elbow, or rotator cuff issues.

Post-Surgical Recovery

After surgery, your body needs to repair a lot of tissue quickly. TB-500 supports wound healing, reduces inflammation, and may help minimize scar tissue formation. Some protocols use it alongside traditional recovery to potentially speed up the healing timeline.

Chronic Inflammation and Slow Healers

Some people just heal slowly—whether due to age, diabetes, or other factors. TB-500 helps regulate the inflammatory response and promotes the cellular processes needed for tissue repair. It essentially tells your body to focus healing resources where they're needed most.

Safety Profile

Sideeffects

Common

Injection site redness

Injection site swelling

Uncommon

Temporary mild headache

Mild bruising at injection site

Transient fatigue

Serious

Allergic reaction

Mild fatigue or lethargy

Mild headache

Slight flushing

Head rush or lightheadedness

Temporary nausea

Research Status

Safety& evidence

FDA Status

Research compound

Safety Overview

Thymosin Beta-4 is a naturally occurring peptide found in all cells and body fluids in the human body. Clinical trials have demonstrated excellent safety even at very high doses. IV studies showed doses up to 1260 mg were well tolerated with no serious adverse events.

Contraindications

xActive systemic infections

xSevere immunosuppression

xHypersensitivity to thymosin or any component

xPregnancy (insufficient safety data)

TB-500 has shown a good safety profile across preclinical studies and limited human research. It's a fragment of thymosin beta-4, a naturally occurring protein in your body involved in healing. Most side effects are mild and transient, primarily injection site reactions. However, large-scale clinical trials are still needed to fully establish its safety profile in humans.

xPregnancy or planning to become pregnant

xCurrently breastfeeding

xActive cancer or history of cancer

xKnown allergy to peptide components

xChildren and adolescents

Decision Guide

Which isright for you?

Choose Thymosin Beta-4 if...

Recovering from injuries or surgery

Improving wound healing speed

Reducing inflammation

Minimizing scar formation

Choose TB-500 if...

Accelerating injury recovery

Tendon and ligament healing

Reducing chronic inflammation

Post-surgical recovery support

Connected topics

Follow this recovery question